Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.37 |
| ▸ | ITGAV | P06756 | 16/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5972656 | 0.98 | ITGB3 (0.37) | ITGB3ITGAVITGA2B | |
| SCHEMBL7254424 | 0.94 | ITGB3 (0.36) | ITGB3ITGAVITGA2B | |
| SCHEMBL5977658 | 0.92 | ITGB3 (0.39) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972921 | 0.92 | ITGB3 (0.39) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972525 | 0.89 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| SCHEMBL5973057 | 0.84 | ITGB3 (0.45) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972945 | 0.82 | ITGB3 (0.42) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972886 | 0.81 | ITGB3 (0.45) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972483 | 0.79 | ITGB3 (0.53) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972537 | 0.75 | ITGB3 (0.53) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6558649-B1 | Benzodiazepine nonpeptide targeting moiety bound to chelating group; diagnosis and treatment of cancer; imaging tumors; monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-05-06 | — | — | US | disclosed |